|
Volumn 13, Issue 2, 2007, Pages 92-94
|
Advances in management of acute promyelocyte leukemia with arsenic trioxide
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACCRA;
ALPHA INTERFERON;
ANTHRACYCLINE DERIVATIVE;
ARSENIC TRIOXIDE;
CYTARABINE;
DAUNORUBICIN;
GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;
IDARUBICIN;
MERCAPTOPURINE;
METHOTREXATE;
MITOXANFRONE;
RETINOIC ACID;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
CHROMOSOME 21Q;
CHROMOSOME 22Q;
CHROMOSOME TRANSLOCATION 15;
CHROMOSOME TRANSLOCATION 17;
CLINICAL OBSERVATION;
COMBINATION CHEMOTHERAPY;
DISEASE FREE SURVIVAL;
DRUG MECHANISM;
FUSION GENE;
HEART VENTRICLE EXTRASYSTOLE;
HEART VENTRICLE TACHYCARDIA;
HEMATOLOGY;
HUMAN;
KIDNEY DYSFUNCTION;
LEUKOCYTE;
LIVER INJURY;
MENTAL DISEASE;
MONOTHERAPY;
MORTALITY;
POLYMERASE CHAIN REACTION;
PRIORITY JOURNAL;
PROMYELOCYTIC LEUKEMIA;
QT PROLONGATION;
RELAPSE;
SHORT SURVEY;
SIDE EFFECT;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARSENICALS;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
OXIDES;
TRETINOIN;
|
EID: 34447260463
PISSN: 16720415
EISSN: None
Source Type: Journal
DOI: 10.1007/s11655-007-0092-y Document Type: Short Survey |
Times cited : (1)
|
References (6)
|